Home > > Global Smart Pill Technology Market Report
The Smart Pill Technology market was valued at $3,580.2 Million in 2023, and is projected to reach $5,748.8 Million by 2030 growing at a CAGR of 7.06% from 2024 to 2030. Capsule Endoscopy segment is expected to be the highest contributor to this market, with $1,891.8 Million in 2023, and is anticipated to reach $2,880.3 Million by 2030, registering a CAGR of 6.25%. Drug Delivery segment is anticipated to reach $1,715.9 Million by 2030 with the highest CAGR of 7.96%. Capsule Endoscopy and Drug Delivery segments collectively expected to account for about 81.0% share of the Smart Pill Technology market in 2023, with the former constituting around 52.8% share. Drug Delivery and Patient Monitoring segments are expected to witness significant growth rates at a CAGR of 7.96% and 7.86% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 47.2% in the overall Smart Pill Technology market in 2023, and is anticipated to reach 49.9% by 2030. Application Capsule Endoscopy Drug Delivery Patient Monitoring Target Area Esophagus Stomach Small Intestine Large Intestine Disease Indication Barrett's Esophagus Small Bowel Diseases Colon Cancer Other Disease Indications End User Hospitals and Clinics Diagnostic Centers Research Centers BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA